DEA Adjusts 2020 Quotas for Controlled Substances in Response to COVID Pandemic
The Drug Enforcement Administration is adjusting 2020 production quotas for controlled substances in schedule II of the Controlled Substances Act, as well as quotas for the manufacture and importation of the Schedule I chemicals ephedrine, phenylpropanolamine and pseudoephedrine. “This increase is in response to the current nationwide COVID-19 public health emergency,” the DEA said.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
(Federal Register 04/10/20)